Trade Summary

6 days ago, SEBULSKY ALAN, serving as Dir at Parabilis Medicines, Inc. (PBLS), purchased 17,500 shares at $27.06 per share, for a total transaction value of $473,528.54. Following this transaction, SEBULSKY ALAN now holds 30,000 shares of PBLS.

This purchase represents a 140.00% increase in SEBULSKY ALAN's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Friday, June 12, 2026 and publicly disclosed via SEC Form 4 filing on Tuesday, June 16, 2026 at 6:19 PM ET, 4 days after the trade was made.

Parabilis Medicines, Inc. operates in the NONE sector, specifically within the NONE industry. Insider buying activity in this sector can provide valuable signals about industry trends and company-specific developments.